Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Toxin Mechanisms and Immunotoxins
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the development and efficacy of immunotoxin therapy for cancer treatment, with a particular emphasis on ricin poisoning, ribosome-inactivating proteins, and targeted therapy using recombinant immunotoxins. It also explores the use of IL-13 receptor and mistletoe extract in cancer therapy.
102
Works
IDs:OpenAlex
How has Toxin Mechanisms and Immunotoxins's publication output changed over time?
ScholarIQpublication output · 1999–2017
Output grew0% over the shown period — from 1 works in 1999 to 1 in 2017.
1
1
1
2
2
1
1
1
1
1
1999200120022003200520112013201420162017
What are the most-cited papers on Toxin Mechanisms and Immunotoxins?
ScholarIQmost cited works
IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis
Stefan Fichtner‐Feigl, Warren Strober, Koji Kawakami, Raj K. Puri, Atsushi Kitani
Nature Medicine. 2005884 Citations
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Garth Powis, Rosanne Bonjouklian, Margareta Berggren, Alfred Gallegos, Robert T. Abraham, Curtis L. Ashendel, Leon H. Zalkow, William F. Matter, Jeffrey A. Dodge, Gerald B. Grindey
PubMed. 1994692 Citations
Ricin Poisoning
Jennifer Audi, Martin Belson, Manish M. Patel, Joshua G. Schier, John Osterloh
JAMA. 2005627 Citations
The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer
E Asbrink, A. Hovmark, B Hederstedt
Acta Dermato Venereologica. 1984221 CitationsOPEN ACCESS
The interleukin-13 receptor α2 chain: an essential component for binding and internalization but not for interleukin-13–induced signal transduction through the STAT6 pathway
Koji Kawakami, Jun Taguchi, Takashi Murata, Raj K. Puri
Blood. 2001216 CitationsOPEN ACCESS
Where is Toxin Mechanisms and Immunotoxins research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Toxin Mechanisms and Immunotoxins is open access?
ScholarIQopen access share
47%OPEN ACCESS
Gold
7%
Green
13%
Hybrid
13%
Bronze
13%
Closed
53%
Related on ScholarIQ
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Paper
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Paper
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
Paper
IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis
Paper
Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
Paper
Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes.
Paper